LivaNova Launched SenTiva DUO, an Implantable Pulse Generator
On February 3, 2023, LivaNova PLC, a market-leading medical technology and innovation company launched SenTiva DUO™, an implantable pulse generator (IPG) with a dual-pin header that delivers VNS Therapy™ for the treatment of drug-resistant epilepsy.
This most recent IPG differs from the original SenTiva™, which was only offered in a single-pin format, by having a dual-pin header. Patients who were initially implanted with a dual-pin lead and IPG are now able to benefit from the most recent advancements in VNS Therapy, owing to the new SenTiva DUO.
The therapeutic advantag...
